4.1 Interventions to raise haemoglobin levels in patients with malignancies

Background question 1

In patients with malignancies (solid tumours) undergoing radiotherapy, do interventions (transfusion or ESAs) aimed at raising the Hb concentration during radiotherapy affect patient outcomes (e.g. response rate, tumour recurrence or tumour-free survival)?

ESA, erythropoiesis-stimulating agent; Hb, haemoglobin